Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/15/2021
Closing price: 275.84
|Support price level:||$274.84|
|Resistance price level:||N/A|
|Relative strength index (14-day RSI)||75.8|
- Up 9.2 percent, BIIB is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 11.1% in the next week.
- 25.3% in the next month.
- 107.7% in the next year.